Genome Editing Technologies and Human Germline Genetic Modification: The Hinxton Group Consensus Statement

Hinxton Group

doi:10.1080/15265161.2015.1103814

Genome Editing Technologies and Human Germline Genetic Modification: The Hinxton Group Consensus Statement

Hinxton Group

Academic Centers

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Original language	English (US)
Pages (from-to)	42-47
Number of pages	6
Journal	American Journal of Bioethics
Volume	15
Issue number	12
DOIs	https://doi.org/10.1080/15265161.2015.1103814
State	Published - 2015

ASJC Scopus subject areas

Issues, ethics and legal aspects
Health Policy

Access to Document

10.1080/15265161.2015.1103814

Cite this

@article{211179c9915c44ba975b2b99dc196007,

title = "Genome Editing Technologies and Human Germline Genetic Modification: The Hinxton Group Consensus Statement",

author = "{Hinxton Group} and Sarah Chan and Donovan, {Peter J.} and Thomas Douglas and Christopher Gyngell and John Harris and Robin Lovell-Badge and Mathews, {Debra J.H.} and Alan Regenberg",

note = "Funding Information: We gratefully acknowledge the generous support of the institutions funding this work: the Wellcome Trust, the Medical Research Council, the Johns Hopkins Berman Institute of Bioethics, the University of Manchester Institute for Science, Ethics and Innovation, the University of Manchester Institute of Biotechnology, the Centre of Genomics and Policy, and McGill University. ■",

year = "2015",

doi = "10.1080/15265161.2015.1103814",

language = "English (US)",

volume = "15",

pages = "42--47",

journal = "American Journal of Bioethics",

issn = "1526-5161",

publisher = "Routledge",

number = "12",

}

TY - JOUR

T1 - Genome Editing Technologies and Human Germline Genetic Modification

T2 - The Hinxton Group Consensus Statement

AU - Hinxton Group

AU - Chan, Sarah

AU - Donovan, Peter J.

AU - Douglas, Thomas

AU - Gyngell, Christopher

AU - Harris, John

AU - Lovell-Badge, Robin

AU - Mathews, Debra J.H.

AU - Regenberg, Alan

N1 - Funding Information: We gratefully acknowledge the generous support of the institutions funding this work: the Wellcome Trust, the Medical Research Council, the Johns Hopkins Berman Institute of Bioethics, the University of Manchester Institute for Science, Ethics and Innovation, the University of Manchester Institute of Biotechnology, the Centre of Genomics and Policy, and McGill University. ■

PY - 2015

Y1 - 2015

UR - http://www.scopus.com/inward/record.url?scp=84983215129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983215129&partnerID=8YFLogxK

U2 - 10.1080/15265161.2015.1103814

DO - 10.1080/15265161.2015.1103814

M3 - Article

C2 - 26632362

AN - SCOPUS:84983215129

SN - 1526-5161

VL - 15

SP - 42

EP - 47

JO - American Journal of Bioethics

JF - American Journal of Bioethics

IS - 12

ER -

Genome Editing Technologies and Human Germline Genetic Modification: The Hinxton Group Consensus Statement

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this